• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三尖瓣反流管理中的当前未满足需求及解决线索

Current Unmet Needs and Clues to the Solution in the Management of Tricuspid Regurgitation.

作者信息

Sun Byung Joo, Park Jae-Hyeong

机构信息

Division of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.

出版信息

Korean Circ J. 2022 Jun;52(6):414-428. doi: 10.4070/kcj.2022.0117.

DOI:10.4070/kcj.2022.0117
PMID:35656901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9160646/
Abstract

Although tricuspid regurgitation (TR) is a general medical issue with growing prevalence and socioeconomic burden, most clinicians have not paid much attention to TR in the past. Several problems of TR have been pointed out in clinical practice, which include: ambiguous clinical manifestations and the difficulty in initial detection, limitations in generally used diagnostic tools, the absence of objective criterion for therapeutic intervention, high operative morbidity and mortality, and lack of long-term clinical data after the intervention for TR. Therefore, patients with TR usually visit clinicians at a much-advanced state, and this delay gives a major dilemma in clinical decision-making in a routine clinical practice. To improve the clinical outcome of TR, we need more knowledge about TR for solving the current problems and making strategies for better clinical practice. With this background, we have discussed in the present article about the pathophysiology of TR and the problems frequently experienced by clinical physicians in the diagnosis and treatment of TR. Furthermore, we have discussed the future strategy to improve the treatment of TR.

摘要

尽管三尖瓣反流(TR)是一个普遍的医学问题,其患病率和社会经济负担不断增加,但过去大多数临床医生并未对TR给予太多关注。临床实践中已指出TR的几个问题,包括:临床表现模糊且早期检测困难、常用诊断工具存在局限性、缺乏治疗干预的客观标准、手术发病率和死亡率高以及TR干预后缺乏长期临床数据。因此,TR患者通常在病情非常严重时才就医,这种延误给常规临床实践中的临床决策带来了重大困境。为改善TR的临床结局,我们需要更多关于TR的知识来解决当前问题并制定更好的临床实践策略。在此背景下,我们在本文中讨论了TR的病理生理学以及临床医生在TR诊断和治疗中经常遇到的问题。此外,我们还讨论了改善TR治疗的未来策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556d/9160646/2fdaabb8ccd8/kcj-52-414-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556d/9160646/b10cfaf71796/kcj-52-414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556d/9160646/977cf7b66539/kcj-52-414-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556d/9160646/2fdaabb8ccd8/kcj-52-414-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556d/9160646/b10cfaf71796/kcj-52-414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556d/9160646/977cf7b66539/kcj-52-414-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556d/9160646/2fdaabb8ccd8/kcj-52-414-g003.jpg

相似文献

1
Current Unmet Needs and Clues to the Solution in the Management of Tricuspid Regurgitation.三尖瓣反流管理中的当前未满足需求及解决线索
Korean Circ J. 2022 Jun;52(6):414-428. doi: 10.4070/kcj.2022.0117.
2
Management and Outcome of Patients Admitted With Tricuspid Regurgitation in France.法国三尖瓣反流患者的管理和预后。
Can J Cardiol. 2021 Jul;37(7):1078-1085. doi: 10.1016/j.cjca.2020.12.012. Epub 2020 Dec 25.
3
Characteristics and prognosis of patients with significant tricuspid regurgitation.伴有显著三尖瓣反流患者的特征和预后。
Arch Cardiovasc Dis. 2019 Oct;112(10):604-614. doi: 10.1016/j.acvd.2019.06.011. Epub 2019 Sep 23.
4
Tricuspid surgery for tricuspid regurgitation: review.三尖瓣反流的三尖瓣手术:综述
Gen Thorac Cardiovasc Surg. 2016 Oct;64(10):577-83. doi: 10.1007/s11748-016-0678-4. Epub 2016 Jun 27.
5
[Update on tricuspid regurgitation].[三尖瓣反流的最新进展]
G Ital Cardiol (Rome). 2014 Jul-Aug;15(7-8):418-29. doi: 10.1714/1596.17418.
6
Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease.三尖瓣反流的处理:欧洲心脏病学会心血管外科学组和瓣膜性心脏病工作组的立场声明。
Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1022-1030. doi: 10.1093/ejcts/ezx279.
7
Tricuspid valve regurgitation: current diagnosis and treatment.三尖瓣反流:当前的诊断与治疗
Am J Cardiovasc Dis. 2022 Feb 15;12(1):1-18. eCollection 2022.
8
Which patient undergoing mitral valve surgery should also have the tricuspid repair?哪些接受二尖瓣手术的患者也应该进行三尖瓣修复?
Interact Cardiovasc Thorac Surg. 2009 Dec;9(6):1009-20. doi: 10.1510/icvts.2009.217570. Epub 2009 Sep 24.
9
Transcatheter therapy for tricuspid regurgitation: The surgical perspective.经导管三尖瓣反流治疗:手术视角。
Prog Cardiovasc Dis. 2019 Nov-Dec;62(6):473-478. doi: 10.1016/j.pcad.2019.11.016. Epub 2019 Dec 2.
10
Secondary Tricuspid Regurgitation: Pathophysiology, Incidence and Prognosis.继发性三尖瓣反流:病理生理学、发病率及预后
Front Cardiovasc Med. 2021 Jul 22;8:701243. doi: 10.3389/fcvm.2021.701243. eCollection 2021.

引用本文的文献

1
Transcatheter Management of Tricuspid Regurgitation: A Review of Contemporary Evidence.经导管治疗三尖瓣反流:当代证据综述
Heart Int. 2024 Dec 18;18(2):24-36. doi: 10.17925/HI.2024.18.2.4. eCollection 2024.
2
Pivot-Balloon: A First Step Toward a Novel Transcatheter Treatment for Severe Tricuspid Regurgitation.枢轴球囊:迈向严重三尖瓣反流新型经导管治疗的第一步。
Korean Circ J. 2025 Jan;55(1):32-33. doi: 10.4070/kcj.2024.0304. Epub 2024 Oct 8.
3
Speckle tracking echocardiography: a reliable tool for right ventricle function evaluation in severe tricuspid regurgitation.

本文引用的文献

1
Prognostic Impact of Left Atrial Strain After Mitral Valve Repair Surgery in Patients With Severe Mitral Regurgitation.二尖瓣修复术后左心房应变对重度二尖瓣反流患者的预后影响
Korean Circ J. 2022 Mar;52(3):205-217. doi: 10.4070/kcj.2021.0188. Epub 2021 Dec 14.
2
Association between a Multidisciplinary Team Approach and Clinical Outcomes in Patients Undergoing Extracorporeal Cardiopulmonary Resuscitation in the Emergency Department.急诊科接受体外心肺复苏患者多学科团队协作方法与临床结局的关联
Korean Circ J. 2021 Nov;51(11):908-918. doi: 10.4070/kcj.2021.0167. Epub 2021 Aug 27.
3
Prognostic Value of Complementary Echocardiography and Magnetic Resonance Imaging Quantitative Evaluation for Isolated Tricuspid Regurgitation.
斑点追踪超声心动图:评估重度三尖瓣反流时右心室功能的可靠工具。
J Cardiovasc Imaging. 2024 Sep 26;32(1):31. doi: 10.1186/s44348-024-00034-1.
4
Postoperative Outcome in the Patients With Atrial Functional Atrioventricular Valve Insufficiency: Atrial Fibrillation Troubles, Always.心房功能性房室瓣关闭不全患者的术后结局:心房颤动问题始终存在。
Korean Circ J. 2023 Aug;53(8):563-565. doi: 10.4070/kcj.2023.0187.
孤立性三尖瓣反流的补充超声心动图和磁共振成像定量评估的预后价值。
Circ Cardiovasc Imaging. 2021 Sep;14(9):e012211. doi: 10.1161/CIRCIMAGING.120.012211. Epub 2021 Sep 15.
4
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
5
Surgical treatment of severe tricuspid regurgitation.三尖瓣重度反流的外科治疗。
Curr Opin Cardiol. 2021 Sep 1;36(5):538-541. doi: 10.1097/HCO.0000000000000897.
6
Markers of Myocardial Damage Predict Mortality in Patients With Aortic Stenosis.心肌损伤标志物可预测主动脉瓣狭窄患者的死亡率。
J Am Coll Cardiol. 2021 Aug 10;78(6):545-558. doi: 10.1016/j.jacc.2021.05.047.
7
Thirty-six Year Trends in Mortality from Diseases of Circulatory System in Korea.韩国循环系统疾病死亡率的36年趋势
Korean Circ J. 2021 Apr;51(4):320-332. doi: 10.4070/kcj.2020.0424.
8
Replacement Myocardial Fibrosis in Patients With Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling, and Arrhythmia.二尖瓣脱垂患者的心肌纤维化置换:与二尖瓣反流、心室重构和心律失常的关系。
Circulation. 2021 May 4;143(18):1763-1774. doi: 10.1161/CIRCULATIONAHA.120.050214. Epub 2021 Mar 12.
9
Determinants of Morbidity and Mortality Associated With Isolated Tricuspid Valve Surgery.孤立性三尖瓣手术相关发病率和死亡率的决定因素。
J Am Heart Assoc. 2021 Jan 19;10(2):e018417. doi: 10.1161/JAHA.120.018417. Epub 2021 Jan 5.
10
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 ACC/AHA 瓣膜性心脏病患者管理指南:执行摘要:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2021 Feb 2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932. Epub 2020 Dec 17.